JavaScript is disabled for your browser. Some features of this site may not work without it.
The cost-effectiveness of a hybrid closed-loop system compared to continuous subcutaneous insulin infusion and sensor-augmented pump therapy for type 1 diabetes patients with high glucose levels in Norway